期刊文献+

阿司匹林预处理对多囊卵巢综合征行IVF-ET的疗效及其机制研究 被引量:2

Study on the Effect and Mechanism of Aspirin Pretreatment on IVF-ET in Patients with Polycystic Ovary Syndrome
下载PDF
导出
摘要 目的:探讨阿司匹林预处理对多囊卵巢综合征行试管婴儿(invitro fertilization-embryo transfer,IVF-ET)的疗效及其机制。方法:选取2015年1月-2016年6月在珠海市妇幼保健院生殖中心因多囊卵巢综合征行试管婴儿治疗的患者119例,采用随机数字表法将患者分为研究组(62例)和对照组(57例)。研究组在IVF-ET治疗前给予阿司匹林预处理,对照组给予安慰剂治疗。观察比较两组患者的促性腺激素(Gn)使用时间、Gn使用剂量、获卵数、2PN受精率、优质胚胎数、启动日T淋巴细胞、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)及IVF-ET结局。结果:研究组患者的Gn使用时间短于对照组,Gn使用剂量低于对照组,获卵数和优质胚胎数均高于对照组,差异均有统计学意义(P<0.05)。研究组患者的启动日T淋巴细胞、TNF-α和IL-6水平均低于对照组,差异均有统计学意义(P<0.05)。研究组患者的临床妊娠率和胚胎种植率均高于对照组,流产率低于对照组,但差异均无统计学意义(P>0.05)。结论:阿司匹林预处理对多囊卵巢综合征行IVF-ET有积极的临床意义。 Objective: To investigate the effect and mechanism of Aspirin pretreatment on invitro fertilization-embryo transfer ( IVF-ET ) in polyeystic ovary syndrome ( PCOS ) .Method: From January 2015 to June 2016, in the reproductive center of Maternal and Child Health Care Hospital of Zhuhai, 119 patients with polyeystic ovary syndrome were treated with IVF-ET and selected, they were divided into research group ( 62 cases ) and control group ( 57 cases ) according to the random number table method.The research group was given Aspirin before IVF-ET treatment, the control group was given placebo.The Gonadotropin ( Gn ) using time, Gn using dosage, amount of acquired oocytes, high-quality embryos, level of the serum T lymphocytes, TNF- α and IL-6 at the initiation day and clinical results of the two groups were observed and compared.Result: The Gn using time of the research group was shorter than that of the control group, and the dosage of Gn was lower than that of the control group, the amount of the acquired oocytes and high-quality embryos of the research group were all more than those of the control group, the differences were statistically significant ( P〈0.05 ) .The levels of T lymphocytes, TNF-α and IL-6 at the initiation day ofthe research group were lower than those of the control group, the differences were statistically significant ( P〈0.05 ) .The pregnancy rate and implantation rate of research group were higher than those in control group, the abortion rate was lower than that in control group, but the differences were not statistically significant (P〉0.05) .Conclusion: Aspirin pretreatment has positive clinical significance in the treatment of polycystic ovary syndrome with IVF-ET.
出处 《中国医学创新》 CAS 2017年第15期16-19,共4页 Medical Innovation of China
基金 珠海市卫计局医学科研基金项目(2015J017)
关键词 阿司匹林 多囊卵巢综合征 IVF—ET T淋巴细胞 肿瘤坏死因子-α 白介素-6 Aspirin Polycystic ovary syndrome Invitro fertilization-embryo transfer T lymphocytes TNF-α IL-6
  • 相关文献

参考文献6

二级参考文献83

  • 1Theodoros E Pavlidis,Efstathios T Pavlidis,Athanasios K Sakantamis.Advances in prognostic factors in acute pancreatitis:a mini-review[J].Hepatobiliary & Pancreatic Diseases International,2010,9(5):482-486. 被引量:26
  • 2林忠.多囊卵巢综合征与细胞因子的相关性研究[J].中国妇产科临床杂志,2006,7(5):391-393. 被引量:4
  • 3Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research[ J]. Arch Dis Child, 2002, 86(4) : 286-290.
  • 4Furukawa S, Matsubara T, Ichiyama T. Regulation of proinflammatory cytokine cascade in Kawasaki disease[ J]. Nippon Rinsho, 2008, 66(2) : 258-264.
  • 5Lau AC, Duong TT, Ito S, Wilson GJ, Yeang RS. Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease[J]. Clin Exp Immunol, 2009, 157(2) : 300-309.
  • 6Lau AC, Dunng TT, Ito S, Yeung RS. Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease[J]. Arthritis Rheum, 2009, 60(7) : 2131-2141.
  • 7Ahn SY, Jang GC, Shin JS, Shin KM, Kim DS. Tumor necrosis factor-alpha levels and promoter polymorphism in patients with Kawasaki disease in Korea[ J]. Yonsei Med J, 2003, 44 (6) : 1021-1026.
  • 8Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, et al. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease [ J]. Circulation, 2005, 111 ( 1 ) : 38-43.
  • 9Pinna GS, Kafetzis DA, Tselkas OI, Skevaki CL. Kawasaki disease: an overview[J]. Curr Opin Infect Dis, 2008,21 (3) : 263-270.
  • 10Chen J, Huang L, Song M, Yu S, Gao P, Jing J. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells[ J]. J Cardiovasc Pharmacol, 2009, 53(5): 359-367.

共引文献65

同被引文献17

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部